共 172 条
[1]
Manns MP(2017)Hepatitis C virus infection Nat Rev Dis Prim 3 17006-260
[2]
Buti M(2020)Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy Clin Mol Hepatol. 26 251-918
[3]
Gane E(2017)Baseline and breakthrough resistance mutations in HCV patients failing DAAs Sci Rep 7 16017-2210
[4]
Pawlotsky JM(2017)NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome J Hepatol 66 910-1303
[5]
Razavi H(2018)Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant Infect Drug Resist 11 2207-2079
[6]
Terrault N(2016)Geno2pheno[HCV] – a web-based interpretation system to support hepatitis C treatment decisions in the era of direct-acting antiviral agents PLoS One 11 e0155869-504
[7]
Younossi Z(2010)The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res 20 1297-36
[8]
Huang C-F(2009)The sequence alignment/map format and SAMtools Bioinformatics. 25 2078-1972
[9]
Yu M-L(2016)The importance of resistance to direct antiviral drugs in HCV infection in clinical practice J Hepatol 64 486-988
[10]
Paolucci S(2019)Discussion on critical points for a tailored therapy to cure hepatitis C virus infection Clin Mol Hepatol 25 30-600